www.fdanews.com/articles/138181-pfizer-japan-unveils-positive-top-line-phase-iii-results-for-lyrica-in-fibromyalgia

Pfizer Japan Unveils Positive Top-Line Phase III Results for Lyrica in Fibromyalgia

July 7, 2011

Pharmaceutical giant Pfizer’s Japan unit announced positive top-line results for Lyrica in a Phase III study of patients with fibromyalgia in Japan. The company said that further analyses will be conducted on these initial results.
RTT News